Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...

Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today presented new, detailed results from the RELIEVE UCCD phase 2b study of duvakitug, a human IgG1-λ2 ...

The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...

National healthcare leader PAM Health has announced plans to build a 42-bed physical medicine and rehabilitation hospital in Minneola, Florida. The new hospital will create approximately 80 new jobs ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Are you getting enough of the 'good fats' your body needs to stay healthy? Probably not! EPA and DHA omega-3s, nutrients found naturally in fatty fish and marine microalgae, are important for every ...

Stocks followed a familiar pattern this week. To start the week, tariff fears caused traders to sell the news. But as those fears abated, stocks revved higher, and by Thursday, all the major indices ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...

In its fourth quarter 2024 investor letter, Sound Shore Management emphasized stocks such as Teva Pharmaceutical Industries Limited (NYSE:TEVA). Headquartered in Tel Aviv, Israel, Teva ...

Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...